April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Role of Complement in the Protection of Retinal Ganglion Cells in Chronic Ocular Hypertension Model of Glaucoma
Author Affiliations & Notes
  • P. Jha
    Ophthalmology, Jones Eye Institute - UAMS, Little Rock, Arkansas
  • B. Matta
    Ophthalmology/Jones Eye Inst,
    Univ of Arkansas for Med Sci, Little Rock, Arkansas
  • R. G. Tytarenko
    Ophthalmology, Jones Eye Institute - UAMS, Little Rock, Arkansas
  • P. S. Bora
    Ophthalmology/Jones Eye Institute,
    Univ of Arkansas for Med Sci, Little Rock, Arkansas
  • N. S. Bora
    Ophthal, Jones Eye Inst, Univ of Arkansas for Med Sciences, Little Rock, Arkansas
  • Footnotes
    Commercial Relationships  P. Jha, None; B. Matta, None; R.G. Tytarenko, None; P.S. Bora, None; N.S. Bora, None.
  • Footnotes
    Support  NIH grants EY016205 & EY 014623 and Pat & Willard Walker Eye Research Center, Jones Eye Institute, Little Rock, AR
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 3188. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      P. Jha, B. Matta, R. G. Tytarenko, P. S. Bora, N. S. Bora; Role of Complement in the Protection of Retinal Ganglion Cells in Chronic Ocular Hypertension Model of Glaucoma. Invest. Ophthalmol. Vis. Sci. 2010;51(13):3188.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the role of complement in the protection of retinal ganglion cells in chronic ocular hypertension model of glaucoma.

Methods: : Intraocular pressure (IOP) was elevated in the left eye of Lewis rats by laser photocoagulation (two treatments, 7 days apart) of episcleral and limbal veins. The right eye did not receive laser treatment and served as control. Lewis rats were injected with cobra venom factor (CVF, >30 units/rat, i.p.) at day 7, 14, 21, 28, 35 and 49 post-laser, to deplete the complement system and these animals were sacrificed on day 49 post-laser. Control animals received similar treatment with PBS. The retina was harvested from laser-treated eyes as well as untreated control eyes and processed for flow cytometry, paraffin embedding, RNA extraction and protein extraction. Paraffin sections were used for immunostaing for glial fibrillary acidic protein (GFAP), Brn3a, complement component C3, complement membrane attack complex (MAC), TUNEL and caspase-3.

Results: : Immunofluorescent staining demonstrated that CVF treatment resulted in decreased deposition of C3 split products and MAC in the retina of the animals with increased IOP compared to the animals with treated with PBS. Drastic decrease in C3 split products, and MAC in the retina of CVF treated Lewis rats were further demonstrated by Western blot analysis. Depletion of complement by CVF resulted in decrease in GFAP staining in the retina of animals with elevated IOP. Furthermore CVF treatment resulted in reduction of TUNEL and active caspase-3 staining in ganglionic cell layer. Flow cytometric analysis showed that the number of apoptotic cells significantly decreased in retina of CVF-treated rats with increased IOP compared to control rats. Complement depletion also resulted in the protection of RGCs as indicated by increased number of Brn3a+ cells (marker for RGC) in CVF treated rats compared to PBS treated rats with increased IOP.

Conclusions: : Our results provide evidence that complement activation plays a critical role in the development of glaucoma in Lewis rats and the loss of retinal ganglion cells in these animals can be prevented by complement depletion.

Keywords: inflammation • apoptosis/cell death • ganglion cells 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×